ScreenerHero

DEVA Deva Holding A.S.

BIST · TR · Healthcare · Drug Manufacturers - Specialty & Generic · deva.com.tr
89.40TRY+0.45%Mkt Cap: 425.69M $P/E: —

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; systemic hormanal preparations; anti-infective…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap425.69M USD
Enterprise Value490.24M USD
Revenue (TTM)482.40M USD
Gross Profit150.77M USD
Net Income (TTM)-19.30M USD
Revenue/Share100.86 TRY
Last Price89.40 TRY
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.1K
CountryTR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA7.27
EV/Revenue1.02
P/S0.88
P/B0.56
EPS (TTM)-6.79
EPS (Forward)—
52W Range
57.5062% of range109.30
52W High109.30 TRY
52W Low57.50 TRY
Profitability
Gross Margin32.76%
Oper. Margin18.56%
EBITDA Margin13.97%
Profit Margin-4.19%
ROE-3.07%
ROA-2.14%
Growth
Revenue Growth8.40%
Earnings Growth-7.00%
Cash Flow & Leverage
Operating CF126.37M USD
CapEx (TTM)56.55M USD
FCF Margin-16.07%
FCF Yield-18.21%
Net Debt64.56M USD
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity0.23
Current Ratio2.10
Quick Ratio1.24
Book Value/Sh157.64 TRY
Cash/Share17.85 TRY
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 TRY
Div. Yield0.00%
5Y Avg Yield0.30%
Payout Ratio0.00%
Ex-Div DateJun 25, 2024
Pay Date—
Splits
Last Split1:1000
Split DateJan 3, 2005
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.200.02M
Float35.59M
Insiders82.20%
Institutions0.31%
Technical
SMA 5086.84 (+2.9%)
SMA 20072.18 (+23.9%)
Beta-0.08
S&P 52W Chg14.58%
Avg Vol (30d)811.56K
Avg Vol (10d)359.26K
Technical Indicators
RSI (14)44.7
MACD0.9603
MACD Signal2.8576
MACD Hist.-1.8973
BB Upper106.14 TRY
BB Middle96.92 TRY
BB Lower87.70 TRY
BB Width19.02%
ATR (14)4.708 TRY
Vol Ratio (20d)0.43x